CB-31. Imatinib mesylate (SSTI571, Gleevec) up-regulates the activation of P42/P44(MAPK) and correlates with the enhanced proliferation in malignant glioma cells
第一作者机构:[1]Harbin Med Coll, Harbin, Peoples R China;
推荐引用方式(GB/T 7714):
Tan X. Q.,Dong Y. C.,Ren H.,et al.CB-31. Imatinib mesylate (SSTI571, Gleevec) up-regulates the activation of P42/P44(MAPK) and correlates with the enhanced proliferation in malignant glioma cells[J].NEURO-ONCOLOGY.2007,9(4):477-477.
APA:
Tan, X. Q.,Dong, Y. C.,Ren, H.,Xu, H. W.,Jiang, Tao&Rainov, N. G..(2007).CB-31. Imatinib mesylate (SSTI571, Gleevec) up-regulates the activation of P42/P44(MAPK) and correlates with the enhanced proliferation in malignant glioma cells.NEURO-ONCOLOGY,9,(4)
MLA:
Tan, X. Q.,et al."CB-31. Imatinib mesylate (SSTI571, Gleevec) up-regulates the activation of P42/P44(MAPK) and correlates with the enhanced proliferation in malignant glioma cells".NEURO-ONCOLOGY 9..4(2007):477-477